Key result
Standard modifiable cardiovascular risk factors in STEMI linked to ~43% lower in-hospital mortality.
Why the study?
STEMI patients without classic modifiable risk factors have higher post-STEMI mortality, prompting investigation into the relationship between in-hospital mortality and the creatinine/albumin ratio in this population.
Cohort
The creatinine/albumin ratio can serve as a predictor of in-hospital mortality to help identify high-risk STEMI patients who lack standard modifiable risk factors.
Answers are grounded in this paper and cite their sources.
May identify vulnerable SMuRF-negative STEMI patients; creatinine/albumin ratio requires prospective validation before guiding care.
Background: Diabetes, hypertension, hyperlipidemia and smoking are associated with coronary artery disease and ST-elevation myocardial infarction (STEMI). However, patients without any classic risk factors have a higher mortality rate in the post-STEMI period. The aim of this study was to investigate the relationship between in-hospital mortality and creatinine/albumin ratio in patients with STEMI without modifiable risk factors. Materials & methods: All patients included in this study with a diagnosis of STEMI and who underwent primary percutaneous intervention between 2016 and 2020 were retrospectively analyzed. Patients were included in the standard modifiable cardiovascular risk factor (SMuRF) group if at least diabetes, hypertension, smoking or hyperlipidemia was present according to risk factors. Patients without these risk factors were considered the non-SMuRF group. Results: Creatinine/albumin ratio was found to be higher in non-SMuRF patients with mortality (p < 0.001). In multivariate logistic regression analysis, ejection fraction, hemoglobin and SMuRF were found to be inversely associated with in-hospital mortality (odds ratio [OR]: 0.48, 95% CI: 0.35–0.66, p < 0.001; OR: 0.70, 95% CI: 0.56–0.88, p = 0.002; OR: 0.57, 95% CI: 0.34–0.95, p = 0.03, respectively). Conclusion: The creatinine/albumin ratio can be used as a predictor of mortality in these patients; it can help identify high-risk patients beforehand.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2022) conducted a cohort in ST-elevation myocardial infarction (STEMI). Standard modifiable cardiovascular risk factors (SMuRF) and creatinine/albumin ratio vs. Non-SMuRF was evaluated on In-hospital mortality (OR 0.57, 95% CI 0.34-0.95, p=0.03). In patients with STEMI, the presence of standard modifiable cardiovascular risk factors was inversely associated with in-hospital mortality, and higher creatinine/albumin ratio predicted mortality in non-SMuRF patients.
Synapse has enriched 10 related papers. Consider them for comparative context: